Richard Lake
Richard Lake
Verified email at
Cited by
Cited by
Advances in malignant mesothelioma
BWS Robinson, RA Lake
New England Journal of Medicine 353 (15), 1591-1603, 2005
Malignant mesothelioma
BWS Robinson, AW Musk, RA Lake
The Lancet 366 (9483), 397-408, 2005
Immunotherapy and chemotherapy—a practical partnership
RA Lake, BWS Robinson
Nature Reviews Cancer 5 (5), 397-405, 2005
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21. 1 losses in malignant pleural mesothelioma
M Bott, M Brevet, BS Taylor, S Shimizu, T Ito, L Wang, J Creaney, RA Lake, ...
Nature genetics 43 (7), 668-672, 2011
Mesothelin-family proteins and diagnosis of mesothelioma
BWS Robinson, J Creaney, R Lake, A Nowak, AW Musk, N de Klerk, ...
The Lancet 362 (9396), 1612-1616, 2003
Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells
AK Nowak, RA Lake, AL Marzo, B Scott, WR Heath, EJ Collins, ...
The Journal of Immunology 170 (10), 4905-4913, 2003
Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors
AK Nowak, BWS Robinson, RA Lake
Cancer research 63 (15), 4490-4496, 2003
Tumor-specific CD4+ T cells have a major “post-licensing” role in CTL mediated anti-tumor immunity
AL Marzo, BF Kinnear, RA Lake, JJ Frelinger, EJ Collins, BWS Robinson, ...
The Journal of Immunology 165 (11), 6047-6055, 2000
Programmed death ligand 2 in cancer‐induced immune suppression
EN Rozali, SV Hato, BW Robinson, RA Lake, WJ Lesterhuis
Journal of Immunology Research 2012 (1), 656340, 2012
Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy
AK Nowak, BWS Robinson, RA Lake
Cancer research 62 (8), 2353-2358, 2002
Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity
WJ Lesterhuis, A Bosco, MJ Millward, M Small, AK Nowak, RA Lake
Nature Reviews Drug Discovery 16 (4), 264-272, 2017
Tumor antigens are constitutively presented in the draining lymph nodes
AL Marzo, RA Lake, D Lo, L Sherman, A McWilliam, D Nelson, ...
The Journal of Immunology 162 (10), 5838-5845, 1999
Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment
RM Zemek, E De Jong, WL Chin, IS Schuster, VS Fear, TH Casey, ...
Science translational medicine 11 (501), eaav7816, 2019
A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice
WJ Aston, DE Hope, AK Nowak, BW Robinson, RA Lake, WJ Lesterhuis
BMC cancer 17, 1-10, 2017
Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunity
WJ Lesterhuis, J Salmons, AK Nowak, EN Rozali, A Khong, IM Dick, ...
PloS one 8 (4), e61895, 2013
T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors
AL Marzo, RA Lake, BWS Robinson, B Scott
Cancer research 59 (5), 1071-1079, 1999
A novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis
FJH Brims, TM Meniawy, I Duffus, D de Fonseka, A Segal, J Creaney, ...
Journal of Thoracic Oncology 11 (4), 573-582, 2016
New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents
AK Nowak, RA Lake, HL Kindler, BWS Robinson
Seminars in oncology 29 (1), 82-96, 2002
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting …
RG Van der Most, AJ Currie, S Mahendran, A Prosser, A Darabi, ...
Cancer Immunology, Immunotherapy 58, 1219-1228, 2009
Chemotherapy and immunotherapy: mapping the road ahead
AM Cook, WJ Lesterhuis, AK Nowak, RA Lake
Current opinion in immunology 39, 23-29, 2016
The system can't perform the operation now. Try again later.
Articles 1–20